Sep 19, 2025 · Antiphospholipid (AN-te-fos-fo-LIP-id) syndrome is a condition in which the immune system mistakenly makes antibodies that attack tissues in the body. These antibodies can cause …

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases …

Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the …

3 days ago · Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to …

Mar 31, 2026 · Apellis Pharmaceuticals Inc. (APLS) shares soared 140% in Tuesday’s pre-market trade after Biogen Inc. (BIIB) announced that it has agreed to acquire the company in a $5.6 billion deal.

Get the latest Apellis Pharmaceuticals Inc (APLS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

2 days ago · A detailed overview of Apellis Pharmaceuticals, Inc. (APLS) stock, including real-time price, chart, key statistics, news, and more.

Apr 17, 2026 · Complete Apellis Pharmaceuticals Inc. stock information by Barron's. View real-time APLS stock price and news, along with industry-best analysis.

4 days ago · See the latest Apellis Pharmaceuticals Inc stock price (APLS:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Get Apellis Pharmaceuticals Inc (APLS:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.